
ThermoGenesis Holdings THMO
Quarterly report 2024-Q1
added 05-17-2024
ThermoGenesis Holdings DSO Ratio 2011-2026 | THMO
Annual DSO Ratio ThermoGenesis Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.2 | 41.5 | 51.8 | 35.8 | 56.9 | 93 | 97 | 117 | 107 | 99.5 | 87.5 | 61.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 | 35.8 | 74.5 |
Quarterly DSO Ratio ThermoGenesis Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35 | - | 23.8 | 34.7 | 50 | - | 94.2 | 67.5 | 49.8 | - | 55.1 | 42.9 | 66.4 | - | 53.5 | 56.2 | 37.9 | - | 28.7 | 27.1 | 42.9 | - | 44.2 | 68.7 | 78.1 | - | 50.2 | 44 | 66 | 68.7 | 74.8 | 37.2 | 80.4 | 98.5 | 142 | 142 | 157 | 87.8 | 113 | 92.2 | 128 | 99.5 | 114 | 100 | 128 | 84.3 | 89.4 | 86.6 | 106 | 89.7 | 78.6 | 75.7 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 157 | 23.8 | 75.3 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Boston Scientific Corporation
BSX
|
65.7 | $ 62.59 | -0.37 % | $ 92.7 B | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 12.07 | 0.33 % | $ 1.63 B | ||
|
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.59 | 1.2 % | $ 36.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
48.5 | $ 9.7 | 0.73 % | $ 347 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.45 | 1.77 % | $ 129 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 81.19 | 0.17 % | $ 47.5 B | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
FONAR Corporation
FONR
|
237 | $ 18.6 | 0.05 % | $ 122 M | ||
|
Butterfly Network
BFLY
|
76.1 | $ 4.13 | 0.49 % | $ 874 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 36.74 | -0.05 % | $ 5.47 K | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
AxoGen
AXGN
|
40.7 | $ 32.64 | -5.23 % | $ 1.5 B | ||
|
Helius Medical Technologies
HSDT
|
53.3 | $ 1.9 | 2.15 % | $ 1.15 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 9.31 | -2.31 % | $ 717 M | ||
|
Inogen
INGN
|
35.8 | $ 6.36 | 2.42 % | $ 169 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
IRIDEX Corporation
IRIX
|
47.5 | $ 1.0 | 1.66 % | $ 16.9 M | ||
|
IRadimed Corporation
IRMD
|
52.7 | $ 95.66 | -0.59 % | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
58.2 | $ 85.63 | -1.4 % | $ 2.97 B | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Align Technology
ALGN
|
86.7 | $ 171.87 | 0.74 % | $ 12.9 B | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 15.94 | -0.75 % | $ 374 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
LENSAR
LNSR
|
38.9 | $ 5.89 | -2.81 % | $ 70.4 M | ||
|
ClearPoint Neuro
CLPT
|
55.6 | $ 9.38 | 0.11 % | $ 266 M | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Pulmonx Corporation
LUNG
|
50.8 | $ 1.36 | 2.26 % | $ 55.3 M | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Medtronic PLC
MDT
|
68.8 | $ 86.28 | -0.4 % | $ 111 B | ||
|
MiMedx Group
MDXG
|
57.3 | $ 3.88 | -1.02 % | $ 573 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
35.3 | $ 0.7 | 4.84 % | $ 29.3 M | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Orthofix Medical
OFIX
|
60 | $ 11.77 | 2.08 % | $ 466 M | ||
|
PAVmed
PAVM
|
84.8 | $ 10.04 | 1.93 % | $ 6.73 M |